Burchenal JH - Search Results

1

Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).

Kelsen DP, Scher H, Alcock N, Leyland-Jones B, Donner A, Williams L, Greene G, Burchenal JH, Tan C, Philips FS, Young CW. Kelsen DP, et al. Among authors: burchenal jh. Cancer Res. 1982 Nov;42(11):4831-5. Cancer Res. 1982. PMID: 7127319

2

Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer.

Scher HI, Kelsen D, Kalman L, Jones L, Burchenal J, Gralla R. Scher HI, et al. Cancer Chemother Pharmacol. 1984;12(2):101-3. doi: 10.1007/BF00254599. Cancer Chemother Pharmacol. 1984. PMID: 6697424

3

Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum.

Kelsen DP, Ribaud P, Alcock N, Burchenal JH, Young CW, Mathe G. Kelsen DP, et al. Among authors: burchenal jh. Cancer Clin Trials. 1981 Winter;4(4):429-31. Cancer Clin Trials. 1981. PMID: 7318125

4

Biochemical, pharmacological, and phase I clinical evaluation of pseudoisocytidine.

Woodcock TM, Chou TC, Tan CT, Sternberg SS, Philips FS, Young CW, Burchenal JH. Woodcock TM, et al. Among authors: burchenal jh. Cancer Res. 1980 Nov;40(11):4243-9. Cancer Res. 1980. PMID: 7471064 Clinical Trial.

5

Preclinical and phase I studies of malonatoplatinum.

Ribaud P, Kelsen DP, Alcock N, Garcia-Giralt E, Dubouch P, Young CC, Muggia FM, Burchenal JH, Mathé G. Ribaud P, et al. Among authors: burchenal jh. Recent Results Cancer Res. 1980;74:156-62. doi: 10.1007/978-3-642-81488-4_20. Recent Results Cancer Res. 1980. PMID: 7444137

6

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU).

Fanucchi MP, Leyland-Jones B, Young CW, Burchenal JH, Watanabe KA, Fox JJ. Fanucchi MP, et al. Among authors: burchenal jh. Cancer Treat Rep. 1985 Jan;69(1):55-9. Cancer Treat Rep. 1985. PMID: 2981621

7

Phase I evaluation of tetrahydrouridine combined with cytosine arabinoside.

Wong PP, Currie VE, Mackey RW, Krakoff IH, Tan CT, Burchenal JH, Young CW. Wong PP, et al. Among authors: burchenal jh. Cancer Treat Rep. 1979 Aug;63(8):1245-9. Cancer Treat Rep. 1979. PMID: 383291 Clinical Trial.

8

Metabolism and effects of 5-(beta-D-ribofuranosyl)isocytosine in P815 cells.

Chou TC, Burchenal JH, Fox JJ, Watanabe KA, Chu CK, Philips FS. Chou TC, et al. Among authors: burchenal jh. Cancer Res. 1979 Mar;39(3):720-8. Cancer Res. 1979. PMID: 427759

9

Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine.

Chou TC, Burchenal JH, Schmid FA, Braun TJ, Su TL, Watanabe KA, Fox JJ, Philips FS. Chou TC, et al. Among authors: burchenal jh. Cancer Res. 1982 Oct;42(10):3957-63. Cancer Res. 1982. PMID: 7104996 No abstract available.

10

Therapeutic trials and clinical pharmacologic studies of the new terephthalanilide derivative, 2-amino-4,'4"-bis(4-methyl-2-imidazolin-2-yl)-terephthalanilide (AMIT) (NSC 66761).

Van Dyk J, Kreis W, Krakoff IH, Tan CT, Cevik N, Burchenal JH. Van Dyk J, et al. Among authors: burchenal jh. Cancer Res. 1968 Aug;28(8):1566-72. Cancer Res. 1968. PMID: 5692134 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters